RetroSense Therapeutics LLC, a Michigan-based company, announced that it has executed its exclusive, worldwide option and signed a license agreement for novel gene-therapy approaches for treating blindness developed at Wayne State University's School of Medicine. Zhuo-Hua Pan, professor of anatomy and cell biology in the School of Medicine, along with colleagues at Salus University in Pennsylvania, developed the breakthrough therapy and follow-on approaches that offer promise to people suffering with incurable blindness caused by age-related macular degeneration and retinitis pigmentosa - retinal degenerative disorders that are currently incurable. "This license agreement with RetroSense is an exciting example of how critical research is to making discoveries, then getting those discoveries to the market," said Hilary Ratner, vice president for research at Wayne State University.

http://detroit.cbslocal.com/2011/10/18/wayne-state-gets-licenses-for-breakthrough-approaches-to-vision-restoration/
http://www.bio-medicine.org/biology-news-1/Wayne-State-announces-license-agreement-for-breakthrough-approaches-to-vision-restoration-21906-1/
http://www.finroad.com/news/retrosensetherapeuticsannounceslicenseagreementwithwaynestateuniversityforbreakthroughapproachestovisionrestoration.html
http://www.genengnews.com/gen-news-highlights/retrosense-licenses-gene-therapy-for-restoring-vision-from-wayne-state-university/81245834/